Utility of Kynurenic Acid for Non-Invasive Detection of Metastatic Spread to Lymph Nodes in Non-Small Cell Lung Cancer
Open Access
- 1 January 2015
- journal article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 12 (2) , 146-153
Abstract
Background: Kynurenic acid (KYNA) is a side-stream product of the kynurenine metabolic pathway that plays a controversial role in malignancies either enabling escape of malignant cells from immune surveillance or exerting antiproliferative effect on cancer cells, and is associated with differences in invasiveness related to metastatic spread to lymph nodes in lung cancer. Nodal involvement is a significant negative prognostic factor usually considered a contraindication for primary surgical resection.Keywords
This publication has 26 references indexed in Scilit:
- Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancerLung Cancer, 2010
- Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patientsLeukemia Research, 2010
- Towards Effective Immunotherapy for Lung Cancer: Simultaneous Targeting of Tumor-Initiating Cells and Immune Pathways in the Tumor MicroenvironmentImmunotherapy, 2009
- Indoleamine 2,3-dioxygenase (IDO) expression in lung cancerCancer Biology & Therapy, 2007
- Indoleamine 2,3-dioxygenase and tumor-induced toleranceJournal of Clinical Investigation, 2007
- Tryptophan degradation in patients with gynecological cancer correlates with immune activationCancer Letters, 2005
- Immunosuppressive networks in the tumour environment and their therapeutic relevanceNature Reviews Cancer, 2005
- Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.2004
- Cells Expressing Indoleamine 2,3-Dioxygenase Inhibit T Cell ResponsesThe Journal of Immunology, 2002
- Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site.1999